Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 886 AL 900

The Locus Coeruleus in Aging and Alzheimer's Disease: A Postmortem and Brain Imaging Review

Beardmore R, Hou R, Darekar A, Holmes C, Boche D.

J Alzheimers Dis. 2021;83(1):5-22. doi: 10.3233/JAD-210191.

Update on neuroimaging in non-Alzheimer's disease dementia: a focus on the Lewy body disease spectrum

Scamarcia PG, Agosta F, Caso F, Filippi M.

Curr Opin Neurol. 2021 Aug 1;34(4):532-538. doi: 10.1097/WCO.0000000000000958.

Advances in fluorescent probes for detection and imaging of amyloid-β peptides in Alzheimer's disease

Zhang Y, Ding C, Li C, Wang X.

Adv Clin Chem. 2021;103:135-190. doi: 10.1016/bs.acc.2020.08.008. Epub 2021 Feb 15.

Neurobiology of loneliness: a systematic review

Lam JA, Murray ER, Yu KE, Ramsey M, Nguyen TT, Mishra J, Martis B, Thomas ML, Lee EE.

Neuropsychopharmacology. 2021 Oct;46(11):1873-1887. doi: 10.1038/s41386-021-01058-7. Epub 2021 Jul 6.

Efficacy of antidepressant drugs in the treatment of depression in Alzheimer disease patients: A systematic review and network meta-analysis

He Y, Li H, Huang J, Huang S, Bai Y, Li Y, Huang W.

J Psychopharmacol. 2021 Aug;35(8):901-909. doi: 10.1177/02698811211030181. Epub 2021 Jul 9.

History of Magnetic Resonance Imaging: A Trip Down Memory Lane

Viard A, Eustache F, Segobin S.

Neuroscience. 2021 Oct 15;474:3-13. doi: 10.1016/j.neuroscience.2021.06.038. Epub 2021 Jul 6.

Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer's disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma

Michno W, Blennow K, Zetterberg H, Brinkmalm G.

J Neurochem. 2021 Oct;159(2):234-257. doi: 10.1111/jnc.15466. Epub 2021 Jul 27.

Evaluation of [(18)F]-JNJ-64326067-AAA tau PET tracer in humans

Baker SL, Provost K, Thomas W, Whitman AJ, Janabi M, Schmidt ME, Timmers M, Kolb HC, Rabinovici GD, Jagust WJ.

J Cereb Blood Flow Metab. 2021 Dec;41(12):3302-3313. doi: 10.1177/0271678X211031035. Epub 2021 Jul 14.

Mini-Cog for the detection of dementia within a secondary care setting

Chan CC, Fage BA, Burton JK, Smailagic N, Gill SS, Herrmann N, Nikolaou V, Quinn TJ, Noel-Storr AH, Seitz DP.

Cochrane Database Syst Rev. 2021 Jul 14;7(7):CD011414. doi: 10.1002/14651858.CD011414.pub3.

Mini-Cog for the detection of dementia within a primary care setting

Seitz DP, Chan CC, Newton HT, Gill SS, Herrmann N, Smailagic N, Nikolaou V, Fage BA.

Cochrane Database Syst Rev. 2021 Jul 14;7(7):CD011415. doi: 10.1002/14651858.CD011415.pub3.

The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community

Garibotto V, Albert NL, Barthel H, van Berckel B, Boellaard R, Brendel M, Cecchin D, Ekmekcioglu O, van de Giessen E, Guedj E, Lammerstma AA, Semah F, Traub-Weidinger T, Van Weehaeghe D, Morbelli S; EANM Neuroimaging Committee.

Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3033-3036. doi: 10.1007/s00259-021-05485-y.

The In Vivo Diagnosis of Concomitant Alzheimer and Lewy Body Pathology: A Case Report

Muccioli L, Mammana A, Incensi A, Baiardi S, Parchi P, Liguori R, Donadio V.

J Neuropathol Exp Neurol. 2021 Nov 19;80(11):1085–1087. doi: 10.1093/jnen/nlab065. Epub 2021 Jul 20.

Efficacy and Cost-effectiveness of Promotion Methods to Recruit Participants to an Online Screening Registry for Alzheimer Disease Prevention Trials: Observational Study

Sato K, Niimi Y, Ihara R, Suzuki K, Toda T, Iwata A, Iwatsubo T.

J Med Internet Res. 2021 Jul 22;23(7):e26284. doi: 10.2196/26284.

Bilingual experience and intrinsic functional connectivity in adults, aging, and Alzheimer's disease

Jafari Z, Perani D, Kolb BE, Mohajerani MH.

Ann N Y Acad Sci. 2021 Dec;1505(1):8-22. doi: 10.1111/nyas.14666. Epub 2021 Jul 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias